封面
市場調查報告書
商品編碼
2050891

數位療法市場:按應用、產品類型和銷售管道

Digital Therapeutics Market, By Application, By Product Type, By Sales Channel

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年數位療法市場規模為139.3億美元,預計到2033年將達到519.8億美元。預計2026年至2033年,該市場將以20.7%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 139.3億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 20.70% 2033年市場規模預測: 519.8億美元

數位療法(DTx)是指基於實證醫學的、由軟體驅動的治療性介入介入措施,旨在預防、管理或治療疾病。數位療法是數位醫療保健的一個分支,它透過疾病管理軟體將基於實證醫學、經過臨床評估的治療性介入直接提供給患者。

市場動態

慢性病負擔日益加重、COVID-19(疫情)爆發、以患者為中心的醫療保健應用程式日益普及、數位醫療保健解決方案和技術的日益普及以及政府對預防醫學日益重視,這些都是推動全球數位療法市場成長的關鍵因素。

例如,2022 年 2 月,DynamiCare Health Inc. 宣布,美國食品藥物管理局(FDA) 已授予其處方箋藥 DCH-001 突破性醫療器材認定,用於治療使懷孕和分娩複雜化的菸草使用障礙。

此外,AmerisourceBergen計畫於2022年7月推出數位藥物治療(DTx)平台,以方便病患取得創新產品。該平台將使醫生能夠透過電子處方流程輕鬆取得和訂購處方箋和非處方箋藥,並能夠監測患者對數位藥物治療和診斷工具的使用情況。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數,創建了全球數位療法市場主要公司的概況。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球數位療法市場報告的目標受群眾外包括行業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球數位療法市場中使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 全球慢性病負擔日益加重
    • 對病患資料隱私的擔憂
    • 數位療法(DTx)的廣泛應用
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球數位療法市場:依應用領域分類,2021-2033年

  • 糖尿病
  • 肥胖
  • 心血管疾病(CVD)
  • 中樞神經系統疾病
  • 呼吸系統疾病
  • 禁止抽煙
  • 胃腸道疾病(GID)
  • 其他

第5章 全球數位療法市場:依產品類型分類,2021-2033年

  • 軟體
  • 裝置

第6章 全球數位療法市場:依銷售管道分類,2021-2033年

  • 企業對企業 (B2B) 交易
  • 面向消費者(B2C)

第7章 全球數位療法市場:依地區分類,2021-2033年

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情勢

  • Happify, Inc.
  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc.
  • Click Therapeutics, Inc.
  • Fitbit, Inc.(Twine Health, Inc.)

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI5865

Digital Therapeutics Market is estimated to be valued at USD 13.93 Bn in 2026 and is expected to reach USD 51.98 Bn by 2033, growing at a compound annual growth rate (CAGR) of 20.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13.93 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 20.70% 2033 Value Projection: USD 51.98 Bn

Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by the software to prevent, manage, or treat a medical disorder or disease. Digital Therapeutics are a part of the digital healthcare that deliver therapeutic interventions directly to patients via evidence-based, clinically-evaluated software for disease management.

Market Dynamics

Increasing burden of chronic diseases, the outbreak of COVID-19 (pandemic), increasing adoption of patient-centric healthcare apps, growing adoption of digital healthcare solutions or technologies, and increasing focus toward preventive healthcare by governments are major factors expected to augment the growth of the global digital therapeutics market.

For instance, in February 2022, DynamiCare Health Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the DCH-001, a prescription-only digital therapeutic to treat tobacco use disorder complicating pregnancy and childbirth.

Moreover, in July 2022, AmerisourceBergen planned to launch digital therapeutics (DTx) platform to facilitate access to innovative products. The platform enables doctors to easily access and order prescription and non-prescription DTx through their e-prescribing workflow and monitor patient fulfilment of digital therapeutics and diagnostics.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital therapeutics market.

Market Segmentation

  • Global Digital Therapeutics Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others
  • Global Digital Therapeutics Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Software
  • Device
  • Global Digital Therapeutics Market, By Sales Channel (Revenue, USD Bn, 2021 - 2033)
  • Business-to-Business (B2B)
  • Employer
  • Healthcare Provider
  • Others
  • Business-to-Consumer (B2C)
  • Patient
  • Caregiver
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Happify, Inc.
  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc.
  • Click Therapeutics, Inc.
  • Fitbit, Inc. (Twine Health, Inc.).

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sales Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of chronic diseases around the world
    • Concerns about patient data privacy
    • Increasing adoption of digital therapeutics (DTx)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Digital Therapeutics Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Obesity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Cardiovascular Disease (CVD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Central Nervous System (CNS) Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Smoking Cessation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Gastrointestinal Disorder (GID)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Digital Therapeutics Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Device
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Digital Therapeutics Market, By Sales Channel, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Business-to-Business (B2B)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Employer
      • Healthcare Provider
      • Others
  • Business-to-Consumer (B2C)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Patient
      • Caregiver

7. Global Digital Therapeutics Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)

8. Competitive Landscape

  • Happify, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 2Morrow, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akili Interactive Labs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Click Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fitbit, Inc. (Twine Health, Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us